Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P17
Within normal range
vs 3Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -27.09% |
| 2023 | 65.82% |
| 2022 | 290.55% |
| 2021 | 1543.78% |
| 2020 | 50.78% |
| 2019 | -79.31% |
| 2018 | 0.00% |